Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: PPIAL4G (peptidylprolyl isomerase A like 4G) Homo sapiens
Symbol: PPIAL4G
Name: peptidylprolyl isomerase A like 4G
Description: Predicted to have cyclosporin A binding activity; peptidyl-prolyl cis-trans isomerase activity; and unfolded protein binding activity. Predicted to be involved in protein refolding. Predicted to localize to the cytoplasm; INTERACTS WITH (-)-epigallocatechin 3-gallate; caffeine; crocidolite asbestos.
Type: protein-coding
RefSeq Status: INFERRED
Also known as: BX284650.5; chromosome 1-amplified sequence 2; COAS-2; FLJ16804; MGC163248; MGC163250; peptidyl-prolyl cis-trans isomerase A-like 4G; peptidylprolyl cis-trans isomerase A-like 4; peptidylprolyl cis-trans isomerase A-like 4A; peptidylprolyl cis-trans isomerase A-like 4G; peptidylprolyl isomerase A (cyclophilin A)-like 4G; PPIAL4A; PPIase A-like 4A; PPIase A-like 4G
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh38 Ensembl1148,479,824 - 148,483,679 (-)Ensembl
GRCh381148,482,548 - 148,483,528 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh371143,767,144 - 143,767,881 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 361142,555,943 - 142,559,798 (-)NCBINCBI36hg18NCBI36
Cytogenetic Map1q21.2NCBI
CHM1_11149,850,674 - 149,851,411 (-)NCBICHM1_1
JBrowse: View Region in Genome Browser (JBrowse)

Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated


Comparative Map Data
Position Markers
miRNA Target Status


RNA-SEQ Expression


Nucleotide Sequences
Protein Sequences
Clinical Variants

Additional Information

External Database Links
Nomenclature History
More on PPIAL4G
Alliance Gene
Ensembl Gene
JBrowse: hg19 hg38
HGNC Report
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 2301115
Created: 2008-09-26
Species: Homo sapiens
Last Modified: 2019-12-25
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.